Literature DB >> 30108894

Integrating docking scores and key interaction profiles to improve the accuracy of molecular docking: towards novel B-RafV600E inhibitors.

Chun-Qi Hu1,2,3, Kang Li1,4, Ting-Ting Yao1, Yong-Zhou Hu1, Hua-Zhou Ying1, Xiao-Wu Dong1.   

Abstract

A set of ninety-eight B-RafV600E inhibitors was used for the development of a molecular docking based QSAR model using linear and non-linear regression models. The integration of docking scores and key interaction profiles significantly improved the accuracy of the QSAR models, providing reasonable statistical parameters (Rtrain2 = 0.935, Rtest2 = 0.728 and QCV2 = 0.905). The established MD-SVR (molecular docking based SMV regression) model as well as model screening of a natural product database was carried out and two natural products (quercetin and myricetin) with good prediction activities were biologically evaluated. Both compounds exhibited promising B-RafV600E inhibitory activities (ICQuercetin50 = 7.59 μM and ICMyricetin50 = 1.56 μM), suggesting a high reliability and good applicability of the established MD-SVR model in the future development of B-RafV600E inhibitors with high efficacy.

Entities:  

Year:  2017        PMID: 30108894      PMCID: PMC6084233          DOI: 10.1039/c7md00229g

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  25 in total

1.  Screening of synthetic and natural product databases: Identification of novel androgens and antiandrogens.

Authors:  Claudia Bobach; Stephanie Tennstedt; Kristin Palberg; Annika Denkert; Wolfgang Brandt; Armin de Meijere; Barbara Seliger; Ludger A Wessjohann
Journal:  Eur J Med Chem       Date:  2014-11-13       Impact factor: 6.514

2.  Development of a novel class of B-Raf(V600E)-selective inhibitors through virtual screening and hierarchical hit optimization.

Authors:  Xiangqian Kong; Jie Qin; Zeng Li; Adina Vultur; Linjiang Tong; Enguang Feng; Geena Rajan; Shien Liu; Junyan Lu; Zhongjie Liang; Mingyue Zheng; Weiliang Zhu; Hualiang Jiang; Meenhard Herlyn; Hong Liu; Ronen Marmorstein; Cheng Luo
Journal:  Org Biomol Chem       Date:  2012-09-28       Impact factor: 3.876

3.  Structure-based drug design using GPCR homology modeling: toward the discovery of novel selective CysLT2 antagonists.

Authors:  Xiaowu Dong; Yanmei Zhao; Xueqin Huang; Kana Lin; Jianzhong Chen; Erqing Wei; Tao Liu; Yongzhou Hu
Journal:  Eur J Med Chem       Date:  2013-02-09       Impact factor: 6.514

4.  Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties.

Authors:  Simon Mathieu; Stefan N Gradl; Li Ren; Zhaoyang Wen; Ignacio Aliagas; Janet Gunzner-Toste; Wendy Lee; Rebecca Pulk; Guiling Zhao; Bruno Alicke; Jason W Boggs; Alex J Buckmelter; Edna F Choo; Victoria Dinkel; Susan L Gloor; Stephen E Gould; Joshua D Hansen; Gregg Hastings; Georgia Hatzivassiliou; Ellen R Laird; David Moreno; Yingqing Ran; Walter C Voegtli; Steve Wenglowsky; Jonas Grina; Joachim Rudolph
Journal:  J Med Chem       Date:  2012-02-29       Impact factor: 7.446

5.  Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitors.

Authors:  Wenhu Zhan; Daqiang Li; Jinxin Che; Liangren Zhang; Bo Yang; Yongzhou Hu; Tao Liu; Xiaowu Dong
Journal:  Eur J Med Chem       Date:  2014-01-22       Impact factor: 6.514

6.  Using Support Vector Machine (SVM) for Classification of Selectivity of H1N1 Neuraminidase Inhibitors.

Authors:  Yang Li; Yue Kong; Mengdi Zhang; Aixia Yan; Zhenming Liu
Journal:  Mol Inform       Date:  2016-01-15       Impact factor: 3.353

7.  Non-oxime inhibitors of B-Raf(V600E) kinase.

Authors:  Li Ren; Steve Wenglowsky; Greg Miknis; Bryson Rast; Alex J Buckmelter; Robert J Ely; Stephen Schlachter; Ellen R Laird; Nikole Randolph; Michele Callejo; Matthew Martinson; Sarah Galbraith; Barbara J Brandhuber; Guy Vigers; Tony Morales; Walter C Voegtli; Joseph Lyssikatos
Journal:  Bioorg Med Chem Lett       Date:  2010-12-19       Impact factor: 2.823

8.  The crystal structure of BRAF in complex with an organoruthenium inhibitor reveals a mechanism for inhibition of an active form of BRAF kinase.

Authors:  Peng Xie; Craig Streu; Jie Qin; Howard Bregman; Nicholas Pagano; Eric Meggers; Ronen Marmorstein
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

9.  Structure-based virtual ligand screening with LigandFit: pose prediction and enrichment of compound collections.

Authors:  Matthieu Montes; Maria A Miteva; Bruno O Villoutreix
Journal:  Proteins       Date:  2007-08-15

10.  Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.

Authors:  Qingda Zang; Daniel M Rotroff; Richard S Judson
Journal:  J Chem Inf Model       Date:  2013-12-11       Impact factor: 4.956

View more
  1 in total

1.  Identification of Novel Covalent XPO1 Inhibitors Based on a Hybrid Virtual Screening Strategy.

Authors:  Zheyuan Shen; Weihao Zhuang; Kang Li; Yu Guo; Bingxue Qu; Sikang Chen; Jian Gao; Jing Liu; Lei Xu; Xiaowu Dong; Jinxin Che; Qimeng Li
Journal:  Molecules       Date:  2022-04-14       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.